Biotech Food Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Nov
8
2023
OIG General Compliance Program Guidance November 2023 Sheppard, Mullin, Richter & Hampton LLP
Nov
8
2023
Ohio Legalizes Recreational Marijuana, But Employers’ Ability to Enforce Workplace Drug Policies Remains Intact (US) Squire Patton Boggs (US) LLP
Nov
8
2023
Ohio Votes for the Decriminalization of Marijuana Dinsmore & Shohl LLP
Nov
8
2023
Rocky Top Update – A Summary of the Tennessee Medical Cannabis Commission’s October Meeting Bradley Arant Boult Cummings LLP
Nov
8
2023
Ohio Passes Recreational Marijuana Law: What Employers Should Know Jackson Lewis P.C.
Nov
8
2023
Plaintiff Asks Court to Revive Coors Light False Ad Suit Keller and Heckman LLP
Nov
7
2023
Massachusetts: Proceed With Caution - New Vaccination Criteria for Hospitals and Other Licensed Health Facilities Foley & Lardner LLP
Nov
7
2023
FDA Updates CFSAN Online Submission Module (COSM) Keller and Heckman LLP
Nov
6
2023
USPTO Report On COVID-19 Diagnostic Patent Filings Foley & Lardner LLP
Nov
6
2023
California’s New Employment Laws for 2024: A Roundup of New Laws Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Nov
6
2023
2023 National Youth Tobacco Survey Shows Significant Decline in High School Vaping Keller and Heckman LLP
Nov
6
2023
Second Circuit Reverses Dismissal of “Reef Friendly” Claims Keller and Heckman LLP
Nov
4
2023
Privacy Tip #378 – Bad Actors Selling Data of 23andMe Users of Ashkenazi Jewish and Chinese Descent Robinson & Cole LLP
Nov
4
2023
Hair Products with Formaldehyde Are Going Out of Style: Is Your Organization Ready for the Change? Sheppard, Mullin, Richter & Hampton LLP
Nov
3
2023
Proposed Amendments to Prop 65’s Warning Requirements Keller and Heckman LLP
Nov
3
2023
FDA LDT Webinar Serves as a Reminder to Industry to Submit Comments on the Proposed Rule Epstein Becker & Green, P.C.
Nov
3
2023
Medical Marketer Convicted of $55 Million Fraud Scheme ArentFox Schiff LLP
Nov
2
2023
FDA Proposes Rule to Prohibit Brominated Vegetable Oil in Food Keller and Heckman LLP
Nov
2
2023
Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] Epstein Becker & Green, P.C.
Nov
1
2023
PFAS in Consumer Products: CPSC Requests Input Keller and Heckman LLP
Nov
1
2023
FDA Issued a Proposed Rule to Amend Prior Notice Regulation Keller and Heckman LLP
Nov
1
2023
PFAS Consumer Fraud Lawsuit Update: New Protein Supplement Case In NY CMBG3 Law
Oct
31
2023
FDA Seeks Comments on Revised Draft Guidance for Communicating Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Keller and Heckman LLP
Oct
31
2023
The Haunting in the Cornfield: Relators’ Qui Tam Claim Confirmed Dead by the Eighth Circuit Bradley Arant Boult Cummings LLP
Oct
31
2023
This is the End: Alabama Medical Cannabis Commission Sets End Game Scenario – Will it Work? Bradley Arant Boult Cummings LLP
Oct
31
2023
FDA: New Draft Guidance on Communication of Unapproved Uses of Approved or Cleared Medical Products Foley & Lardner LLP
Oct
30
2023
Alcohol Industry M&A: Common Pitfalls for Founders (and Avoiding Them) Part One: Formulas and Processes McDermott Will & Emery
Oct
30
2023
District Courts Apply Ninth Circuit Precedent to Dismiss Deceptive Labelling Claims Foley & Lardner LLP
Oct
30
2023
Guidance from FDA Clarifies a Key Issue for Industry: Non-Promotional Presentations About Unapproved Uses of Medical Products Can Be Produced by the Products’ Sponsors Without Violating Off-Label Rules Mintz
Oct
30
2023
High Protections on Information Relating to Employees’ Cannabis Use Sheppard, Mullin, Richter & Hampton LLP
Oct
30
2023
Fast 5: Five Quick Regulatory Takeaways for Pharmaceutical Companies ArentFox Schiff LLP
Oct
30
2023
FDA’s New Enforcement Policy: A Win for Remote Patient Monitoring and Remote Therapeutic Monitoring Manufacturers Foley & Lardner LLP
Oct
30
2023
Study Finds One-Third of Chocolate Contains High Levels of Heavy Metals Keller and Heckman LLP
Oct
30
2023
Compensation for Food Handler Certification in California Jackson Lewis P.C.
Oct
27
2023
HRSA Issues Notice Confirming 340B Registration Requirement McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins